Expression conditions and characterization of a novelly constructed lipoprotein intended as a vaccine to prevent human Haemophilus influenzae infections
Journal of Biological Chemistry · 2023
DOI: 10.1016/j.jbc.2023.105031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Ravinder Kaur und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York, USA. Electronic address: Ravinder.…. Hauptthemen laut MEDLINE: Haemophilus Vaccines, Haemophilus Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, National Institute on Deafness and Other Communication Disorders.
Abstract (Originalsprache)
Bacterial lipoproteins are structurally divided into two groups, based on their lipid moieties: diacylated (present in Gram-positive bacteria) and triacylated (present in some Gram-positive and most Gram-negative bacteria). Diacylated and triacylated lipid moieties differ by a single amide-linked fatty acid chain. Lipoproteins induce host innate immune responses by the mammalian Toll-like receptor 2 (TLR2). In this study, we added a lipid moiety to recombinant OMP26, a native nonlipidated (NL) membrane protein of Haemophilus influenzae, and characterized it extensively under different expression conditions using flow cytometry, LC/MS, and MALDI-TOF. We also investigated the ability of NL and lipidated (L) OMP26 to induce in vitro stimulation of HEK Blue-hTLR2-TR1 and hTLR-TLR6 cells. Our L-OMP26 was predominantly expressed in diacylated form, so we employed an additional gene copy of apolipoprotein N-acetyltransferase enzyme (Lnt)-rich Escherichia coli strain that further acylates the diacyl lipoproteins to enhance the production of triacylated L-OMP26. The diacyl and triacyl versions of L-OMP26, intended as a vaccine for use in humans, were characterized and evaluated as protein vaccine components in a mouse model. We found that the diacyl and triacyl L-OMP26 protein formulations differed markedly in their immune-stimulatory activity, with diacylated L-OMP26 stimulating higher adaptive immune responses compared with triacylated L-OMP26 and both stimulating higher adaptive immune response compared to NL-OMP26. We also constructed and characterized an L-OMP26φNL-P6 fusion protein, where NL-P6 protein (a commonly studied H. influenzae vaccine candidate) was recombinantly fused to L-OMP26. We observed a similar pattern of lipidation (predominantly diacylated) in the L-OMP26φNL-P6 fusion protein.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York, USA. Electronic address: Ravinder.kaur@rochesterregional.org.
- Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York, USA.
- Department of Biochemistry, State University of New York at Buffalo, New York, USA.
- Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York, USA. Electronic address: Michael.pichichero@rochesterregional.org.
Förderung
- NIAID NIH HHS
- National Institutes of Health
- National Institute on Deafness and Other Communication Disorders
Zitieren
APA
Kaur, R., Mangiafesto, J., Pryharski, K., Rasam, S., Zagursky, R., & Pichichero, M. (2023). Expression conditions and characterization of a novelly constructed lipoprotein intended as a vaccine to prevent human Haemophilus influenzae infections. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105031
Vancouver
Kaur R, Mangiafesto J, Pryharski K, Rasam S, Zagursky R, Pichichero M. Expression conditions and characterization of a novelly constructed lipoprotein intended as a vaccine to prevent human Haemophilus influenzae infections. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.105031
BibTeX
@article{Kaur2023,
author = {Kaur, Ravinder and Mangiafesto, Jill and Pryharski, Karin and Rasam, Sailee and Zagursky, Robert and Pichichero, Michael},
title = {Expression conditions and characterization of a novelly constructed lipoprotein intended as a vaccine to prevent human Haemophilus influenzae infections},
journal = {Journal of Biological Chemistry},
year = {2023},
doi = {10.1016/j.jbc.2023.105031}
}
EUVIMED